Exacerbations in Asthma and COPD: A GINA & GOLD Guideline Quiz
Exacerbations of asthma and COPD have a negative impact on disease process in both conditions. Find out what you know about guideline-recommended mitigation.
Moderna Announces Plan to Seek EUA for COVID-19 Vaccine Candidate
Announcement comes after phase 3 study results showed the vaccine candidate was 94.1% effective against COVID-19 and 100% against severe COVID-19.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 30, 2020
US confirmed cases of COVID-19 have surpassed 13 million; global cases have reached 62 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Study: Remission of Obesity-related Complications in Teens Not Dependent on Sustained Weight Loss
Results of a new study suggest that remission of obesity-related complications in adolescents who underwent bariatric surgery is not dependent on sustained weight loss.
Primary Viewpoints Episode 5: Aspirin Found to Reduce COVID-19 Mortality Risk
In episode 5 of Primary Viewpoints, Jonathan Chow, MD, reviews the landmark study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for death.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 25, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Sleep Disorders and Chronic Pain
Pain specialist Steven King, MD, highlights a new review that looks at the complex, bidirectional relationship between sleep disturbance and chronic pain.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 24, 2020
Global confirmed cases of COVID-19 have surpassed 59 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
FDA Issues EUA for Monoclonal Antibodies to Treat COVID-19 in High Risk Patients
The FDA issued an EUA for the investigational antibody cocktail casirivimab and imdevimab for the treatment of mild-to-moderate COVID-19 in high risk patients.
AstraZeneca/Oxford COVID-19 Vaccine Candidate Third to Show Promise
The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.
Thanksgiving 2020: COVID-19 Considerations for Patients
Prepare patients for a safe Thanksgiving with key CDC-based recommendations including alternative Thanksgiving activities, steps to take if exposed to COVID-19, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 23, 2020
US confirmed cases of COVID-19 have surpassed 12 million; global cases have reached 58 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 20, 2020
Global confirmed cases of COVID-19 have surpassed 57 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Obesity and COVID-19: Meet Patients Where They Are
Americans with obesity and overweight are at greater risk for more severe COVID-19. Clinicians can support them best by asking how they can help.
A COVID-19 Thanksgiving: CDC Tips to Give Patients for a Safe Holiday
Ensure your patients have a fun and safe COVID-19 Thanksgiving holiday with these quick CDC-based tips.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 19, 2020
Global confirmed cases of COVID-19 have surpassed 56 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
FDA Issues EUA for First Rapid At-home COVID-19 Diagnostic Test
For the first time, patients at suspected risk of COVID-19 can test themselves at home and see results within 30 minutes.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 18, 2020
Once-weekly Semaglutide 2.0 mg Bests 1.0 mg Dose for A1c, Weight Reduction
Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.
Response to Dupilumab in Severe Asthma Predicted by Baseline FeNo
Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.
